Analyse der Charakteristika primärer Mammakarzinome:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | German |
| Veröffentlicht: |
Freiburg i.Br.
2017
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Inhaltsverzeichnis |
| Beschreibung: | 103 Seiten Diagramme 21 cm |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV045113325 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 180802s2017 gw |||| m||| 00||| ger d | ||
| 015 | |a 18,H04 |2 dnb | ||
| 016 | 7 | |a 1153237806 |2 DE-101 | |
| 020 | |c Broschur | ||
| 035 | |a (OCoLC)1136286525 | ||
| 035 | |a (DE-599)DNB1153237806 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a ger | |
| 044 | |a gw |c XA-DE | ||
| 049 | |a DE-355 | ||
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Martin, Annette Jeanne-Françoise |e Verfasser |0 (DE-588)1142539342 |4 aut | |
| 245 | 1 | 0 | |a Analyse der Charakteristika primärer Mammakarzinome |c vorgelegt von Annette Jeanne-Françoise Martin |
| 264 | 1 | |a Freiburg i.Br. |c 2017 | |
| 300 | |a 103 Seiten |b Diagramme |c 21 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Albert-Ludwigs-Universität Freiburg i.Br. |d 2017 | ||
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 856 | 4 | 2 | |m B:DE-101 |q application/pdf |u http://d-nb.info/1153237806/04 |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030503603&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030503603 | ||
Datensatz im Suchindex
| _version_ | 1804178757050695680 |
|---|---|
| adam_text | 1 INHALTSVERZEICHNIS
1
INHALTSVERZEICHNIS...............................................................................................
4
2 LISTE DER VERWENDETEN ABKUERZUNGEN
.................................................................
6
3 EINLEITUNG
............................................................................
8
3.1 DAS
MAMMAKARZINOM....................................................................................................
8
3.1.1 HAEUFIGKEIT UND
GESCHLECHTSVERTEILUNG...........................................................................8
3.1.2 ALTER UND DEMOGRAPHISCHE
VERTEILUNG...........................................................................8
3.1.3 HISTOLOGISCHE
SUBTYPEN..................................................................................................8
3.1.4 OESTROGEN- UND
PROGESTERON-REZEPTOREN.......................................................................9
3.1.5
HER2-STATUS..................................................................................................................10
3.1.6 MOLEKULARE
SUBTYPEN....................................................................................................
10
3.1.7 GRADING
......
.
..................................................................................................................
11
3.1.8
TNM................................................................................................................................11
3.2
THERAPIEMODALITAETEN.....................................................................................................
12
3.2.1
CHIRURGIE........................................................................................................................
13
3.2.2 ADJUVANTE
CHEMOTHERAPIE............................................................................................14
3.2.3 ADJUVANTE HER2-GERICHTETE
THERAPIE..........................................................................
17
3.2.4 ADJUVANTE
STRAHLENTHERAPIE..........................................................................................17
3.2.5 ADJUVANTE ENDOKRINE
THERAPIE.....................................................................................
19
3.3 KLINISCHES
SETTING.........................................................................................................
19
4
FRAGESTELLUNG.................................................................................................
....20
5 PATIENTINNEN UND METHODEN
..................
21
5.1
SETTING............................................................................................................................
21
5.2
SELEKTIONSKRITERIEN.......................................................................................................
21
5.3 DATENQUELLEN
....
.
...........................................................................................................21
5.4
DATENVERARBEITUNGSPROGRAMM..................................................................................
21
5.4.1 ERFASSTE
MERKMALE........................................................................................................
21
5.4.2 BERECHNETE
PARAMETER.................................................................................................22
5.5
DATENBEREINIGUNG........................................................................................................
23
5.6
DATENAUSWERTUNG.........................................................................................................
24
5.7
ETHIK...............................................................................................................................
24
6
ERGEBNISSE.........................................................................................................
25
6.1
PATIENTINNENCHARAKTERISTIKA.......................................................................................
25
6.1.1 ALTERSVERTEILUNG BEI
ERSTDIAGNOSE................................................................................25
6.1.2
GEWICHTSVERTEILUNG.......................................................................................................26
6.1.3 BETROFFENE
BRUSTSEITE................................................................................................27
6.2
TUMORCHARAKTERISTIKA.................................................................................................27
6.2.1 HISTOLOGISCHER
TUMORTYP..............................................................................................
27
6.2.2 TUMORGROESSE
UND -STADIUM
..........................................................................................
29
6.2.3
GRADING.........................................................................................................................
31
6.2.4 OESTROGEN- UND PROGESTERONREZEPTORSTATUS
.................................................................
32
6.2.5
HER2-STATUS.................................................................................................................
33
6.3
THERAPIE.......................................................................................................................
38
6.3.1
CHIRURGIE.......................................................................................................................
38
6.3.2
CHEMOTHERAPIE.............................................................................................................41
6.3.3 ENDOKRINE
THERAPIE......................................................................................................43
6.3.4
RADIOTHERAPIE...............................................................................................................44
6.4
UEBERLEBENSKURVEN........................................................................................................45
6.4.1
GESAMTUEBERLEBEN.........................................................................................................45
6.4.2 UEBERLEBEN UND HISTOLOGISCHER
TUMORTYP.....................................................................
47
6.4.3 UEBERLEBEN UND
GRADING...............................................................................................
48
6.4.4 UEBERLEBEN UND HORMONREZEPTOR- /
HER2-STATUS........................................................49
6.4.5 UEBERLEBEN UND
REZIDIV................................................................................................
50
6.4.6 UEBERLEBEN UND WEITERE CO-FAKTOREN
..........................................................................
51
7
DISKUSSION.........................................................................................................53
8
ZUSAMMENFASSUNG............................................................................................57
9
LITERATURVERZEICHNIS..........................................................................................58
10
ANHANG...............................................................................................................66
10.1 EIDESSTATTLICHE
VERSICHERUNG...................................................................................
102
10.2
DANKSAGUNG...............................................................................................................
103
|
| any_adam_object | 1 |
| author | Martin, Annette Jeanne-Françoise |
| author_GND | (DE-588)1142539342 |
| author_facet | Martin, Annette Jeanne-Françoise |
| author_role | aut |
| author_sort | Martin, Annette Jeanne-Françoise |
| author_variant | a j f m ajf ajfm |
| building | Verbundindex |
| bvnumber | BV045113325 |
| ctrlnum | (OCoLC)1136286525 (DE-599)DNB1153237806 |
| discipline | Medizin |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01365nam a2200349 c 4500</leader><controlfield tag="001">BV045113325</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">180802s2017 gw |||| m||| 00||| ger d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">18,H04</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1153237806</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="c">Broschur</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1136286525</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1153237806</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Martin, Annette Jeanne-Françoise</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1142539342</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Analyse der Charakteristika primärer Mammakarzinome</subfield><subfield code="c">vorgelegt von Annette Jeanne-Françoise Martin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Freiburg i.Br.</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">103 Seiten</subfield><subfield code="b">Diagramme</subfield><subfield code="c">21 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Albert-Ludwigs-Universität Freiburg i.Br.</subfield><subfield code="d">2017</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://d-nb.info/1153237806/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030503603&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030503603</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV045113325 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:09:02Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030503603 |
| oclc_num | 1136286525 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 103 Seiten Diagramme 21 cm |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| record_format | marc |
| spelling | Martin, Annette Jeanne-Françoise Verfasser (DE-588)1142539342 aut Analyse der Charakteristika primärer Mammakarzinome vorgelegt von Annette Jeanne-Françoise Martin Freiburg i.Br. 2017 103 Seiten Diagramme 21 cm txt rdacontent n rdamedia nc rdacarrier Dissertation Albert-Ludwigs-Universität Freiburg i.Br. 2017 (DE-588)4113937-9 Hochschulschrift gnd-content B:DE-101 application/pdf http://d-nb.info/1153237806/04 Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030503603&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Martin, Annette Jeanne-Françoise Analyse der Charakteristika primärer Mammakarzinome |
| subject_GND | (DE-588)4113937-9 |
| title | Analyse der Charakteristika primärer Mammakarzinome |
| title_auth | Analyse der Charakteristika primärer Mammakarzinome |
| title_exact_search | Analyse der Charakteristika primärer Mammakarzinome |
| title_full | Analyse der Charakteristika primärer Mammakarzinome vorgelegt von Annette Jeanne-Françoise Martin |
| title_fullStr | Analyse der Charakteristika primärer Mammakarzinome vorgelegt von Annette Jeanne-Françoise Martin |
| title_full_unstemmed | Analyse der Charakteristika primärer Mammakarzinome vorgelegt von Annette Jeanne-Françoise Martin |
| title_short | Analyse der Charakteristika primärer Mammakarzinome |
| title_sort | analyse der charakteristika primarer mammakarzinome |
| topic_facet | Hochschulschrift |
| url | http://d-nb.info/1153237806/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030503603&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT martinannettejeannefrancoise analysedercharakteristikaprimarermammakarzinome |
Es ist kein Print-Exemplar vorhanden.
Inhaltsverzeichnis